News

Therapeutic Guidelines announces a strategic partnership to deliver ObesiD, a new clinical resource developed by Advanced Pharmacy Australia (AdPha). The partnership was announced by AdPha President Tom Simpson today at Medicines Management 2025.

The new resource will offer concise guidance on the principles of dosing in patients with obesity, calculators, and evidence-based dosing advice for more than 70 medicines. ObesiD will be available on desktop and mobile apps powered by Therapeutic Guidelines' technology platform.

Therapeutic Guidelines is proud to extend their delivery of trusted, evidence-based resources for Australian healthcare professionals to cover ObesiD, Australian Prescriber, and its renowned product Therapeutic Guidelines.

Subscriptions for ObesiD will be available from March 2026.

You can register your interest now and be among the first to access the new resource.